LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the 18th annual Future Leaders in the Biotech Industry Conference on Friday, April 15 at 9:30 a.m. (ET) in New York.
